Zobrazeno 91 - 100
of 208
pro vyhledávání: '"Ferguson GT"'
Autor:
Ferguson GT; a Pulmonary Research Institute of Southeast Michigan , Farmington Hills , MI , USA., Dalby RN; b Department of Pharmaceutical Sciences , University of Maryland School of Pharmacy , Baltimore , MD , USA.
Publikováno v:
Postgraduate medicine [Postgrad Med] 2018 Aug; Vol. 130 (6), pp. 515-522. Date of Electronic Publication: 2018 Jul 04.
Autor:
Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills., Kerwin EM; Clinical Research Institute of Southern Oregon, PC, Medford., Donohue JF; University of North Carolina School of Medicine, Chapel Hill., Ganapathy V; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts., Tosiello RL; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts., Bollu VK; Abilytic, Inc., Shrewsbury, Massachusetts., Rajagopalan K; Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts.
Publikováno v:
Chronic obstructive pulmonary diseases (Miami, Fla.) [Chronic Obstr Pulm Dis] 2018 Jun 06; Vol. 5 (3), pp. 193-207. Date of Electronic Publication: 2018 Jun 06.
Autor:
Kerwin E; a Clinical Research Institute of Southern Oregon, Inc ., Medford , OR , USA., Ferguson GT; b Pulmonary Research Institute of Southeast Michigan , Farmington Hills , MI , USA.
Publikováno v:
Expert review of respiratory medicine [Expert Rev Respir Med] 2018 Jun; Vol. 12 (6), pp. 447-459. Date of Electronic Publication: 2018 May 28.
Autor:
Pham S; 1 Sunovion Pharmaceuticals, Inc. , Marlborough, Massachusetts., Ferguson GT; 2 Pulmonary Research Institute of Southeast Michigan , Farmington Hills, Michigan., Kerwin E; 3 Clinical Research Institute of Southern Oregon, Inc. , Medford, Oregon., Goodin T; 1 Sunovion Pharmaceuticals, Inc. , Marlborough, Massachusetts., Wheeler A; 1 Sunovion Pharmaceuticals, Inc. , Marlborough, Massachusetts., Bauer A; 1 Sunovion Pharmaceuticals, Inc. , Marlborough, Massachusetts.
Publikováno v:
Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2018 Jun; Vol. 31 (3), pp. 162-169. Date of Electronic Publication: 2017 Nov 10.
Autor:
Maltais F; Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec City, QC, Canada. Electronic address: Francois.Maltais@fmed.ulaval.ca., Buhl R; Pulmonary Department, Mainz University Hospital, Mainz, Germany., Koch A; Medizinische Klinik und Poliklinik V, Klinikum der Ludwig-Maximilians-Universität, and the German Center for Lung Research (DZL), Klinikum der Ludwig-Maximilians-Universität, Munich, Germany., Amatto VC; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Reid J; Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Grönke L; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Bothner U; Boehringer Ingelheim International GmbH, Ingelheim, Germany., Voß F; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., McGarvey L; Centre for Infection and Immunity, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, Northern Ireland., Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI.
Publikováno v:
Chest [Chest] 2018 Jun; Vol. 153 (6), pp. 1315-1325. Date of Electronic Publication: 2018 Jan 31.
Autor:
Porszasz J; Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA. Electronic address: porszasz@ucla.edu., Carraro N; Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA., Cao R; Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA. Electronic address: rcao@labiomed.org., Gore A; Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA., Ma S; Center for Infectious Disease Research, Seattle, WA, USA. Electronic address: shuyima1@illinois.edu., Jiang T; Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA., Maltais F; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Québec, Canada. Electronic address: francois.maltais@med.ulaval.ca., Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA. Electronic address: garytferguson@msn.com., O'Donnell DE; Department of Medicine, Queen's University & Kingston General Hospital, Kingston, ON, Canada. Electronic address: odonnell@queensu.ca., Shaikh A; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA. Electronic address: asif.shaikh@boehringer-ingelheim.com., Rossiter HB; Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA; Faculty of Biological Sciences, University of Leeds, Leeds, UK. Electronic address: hrossiter@ucla.edu., Casaburi R; Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA. Electronic address: casaburi@ucla.edu.
Publikováno v:
Respiratory physiology & neurobiology [Respir Physiol Neurobiol] 2018 May; Vol. 251, pp. 8-15. Date of Electronic Publication: 2018 Feb 10.
Autor:
Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI 48336, USA. Electronic address: garytferguson@msn.com., Reisner C; Pearl Therapeutics Inc., 280 Headquarters Plaza, East Tower, 2nd Floor, Morristown, NJ 07960, USA; AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878, USA. Electronic address: creisner@pearltherapeutics.com., Pearle J; California Research Medical Group, Inc, 301 West Bastanchury Road, Fullerton, CA 92835, USA. Electronic address: jpearlemd@hotmail.com., DePetrillo P; SNBL Clinical Pharmacology Center, Inc, Room 5-15 800 W. Baltimore St., Baltimore, MD 21201, USA. Electronic address: pdepetrillo@snbl-cpc.com., Maes A; Pearl Therapeutics Inc., 280 Headquarters Plaza, East Tower, 2nd Floor, Morristown, NJ 07960, USA. Electronic address: amaes@pearltherapeutics.com., Martin UJ; AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878, USA. Electronic address: Ubaldo.Martin@astrazeneca.com.
Publikováno v:
Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2018 Apr; Vol. 49, pp. 67-74. Date of Electronic Publication: 2018 Feb 04.
Autor:
Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI 48336, USA. Electronic address: garytferguson@msn.com., Hickey AJ; RTI International, Research Triangle Park, NC 27709, USA., Dwivedi S; Pearl Therapeutics, Inc., 200 Cardinal Way, Redwood City, CA 94063, USA.
Publikováno v:
Respiratory medicine [Respir Med] 2018 Jan; Vol. 134, pp. 16-23. Date of Electronic Publication: 2017 Sep 25.
Autor:
Kerwin E; Clinical Research Institute, Medford, OR, USA., Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI, USA., Sanjar S; Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, USA., Goodin T; Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, USA., Yadao A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Fogel R; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Maitra S; Novartis Healthcare Pvt. Ltd., Hyderabad, India., Sen B; Novartis Healthcare Pvt. Ltd., Hyderabad, India., Ayers T; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Banerji D; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. donald.banerji@novartis.com.
Publikováno v:
Lung [Lung] 2017 Dec; Vol. 195 (6), pp. 739-747. Date of Electronic Publication: 2017 Oct 09.
Baseline Symptom Score Impact on Benefits of Glycopyrrolate/Formoterol Metered Dose Inhaler in COPD.
Autor:
Martinez FJ; Joan and Sanford Weill Department of Internal Medicine, Weill Cornell Medicine, New York, NY. Electronic address: fjm2003@med.cornell.edu., Fabbri LM; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy., Ferguson GT; Pulmonary Research Institute of Southeast Michigan, Farmington Hills, MI., Orevillo C; Former employee of Clinical Development, Pearl Therapeutics, Inc, Morristown, NJ., Darken P; Department of Biostatistics, Pearl Therapeutics, Inc, Morristown, NJ., Martin UJ; Respiratory Global Medicines, AstraZeneca, Gaithersburg, MD., Reisner C; Clinical Development and Medical Affairs, Pearl Therapeutics, Inc, Morristown, NJ; and Respiratory Global Medicines, AstraZeneca, Gaithersburg, MD.
Publikováno v:
Chest [Chest] 2017 Dec; Vol. 152 (6), pp. 1169-1178. Date of Electronic Publication: 2017 Jul 16.